[RGLS] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
07-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 26.75%
YoY- 18.91%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 18 18 18 18 18 18 18 0.00%
PBT -13,847 -16,024 -14,506 -15,835 -21,736 -20,025 -20,015 -21.82%
Tax 118 1 -58 -7 -128 -4 5 727.54%
NP -13,847 -16,025 -14,448 -15,828 -21,608 -20,021 -20,020 -21.84%
Tax Rate - - - - - - - -
Total Cost 13,865 16,043 14,466 15,846 21,626 20,039 20,038 -21.82%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -76,927.78 -89,027.78 -80,266.67 -87,933.33 -120,044.44 -111,227.78 -111,222.22 -21.84%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -15.93 -18.49 -16.68 -21.09 -48.76 -45.34 -45.39 -50.34%
EPS Diluted -15.93 -18.49 -16.68 -21.09 -48.76 -45.34 -45.39 -50.34%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.